HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Diethanolamine

This article was originally published in The Rose Sheet

Executive Summary

Diethanolamine: FDA Office of Cosmetics & Colors releases statement Feb. 26 on the agency's Web site to assuage consumer concern regarding diethanolamine and DEA-derived ingredients in cosmetics. "At the present time, there is no reason for consumers to be alarmed based on the usage of these ingredients in cosmetics," FDA states. "Consumers wishing to avoid cosmetics containing DEA or its conjugates may do so by reviewing the ingredient statement required to appear on the outer container label of cosmetics offered for retail sale to consumers," the agency adds. FDA's statement responds to a news piece on "CBS This Morning" Feb. 23 that discussed the NIH National Toxicology Program's December findings suggesting a link between DEA and cancer in lab animals ("The Rose Sheet" Dec. 22, 1997, p. 2). DEA and its esters are found in over 4,000 products, including shampoos and conditioners, according to FDA data. In a separate statement, the Cosmetic, Toiletry and Fragrance Association says "there is no evidence that products containing DEA have been unsafe for consumers"...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005199

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel